| 000 | 01299 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250511193856.0 | ||
| 264 | 0 | _c19920714 | |
| 008 | 199207s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAndrawis, N S | |
| 245 | 0 | 0 |
_aCalcium antagonists block angiotensin II-mediated vasoconstriction in humans: comparison with their effect on phenylephrine-induced vasoconstriction. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cJun 1992 |
||
| 300 |
_a879-84 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngiotensin II _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDiltiazem _xpharmacology |
| 650 | 0 | 4 |
_aForearm _xblood supply |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNifedipine _xpharmacology |
| 650 | 0 | 4 |
_aPhenylephrine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _aCraft, N | |
| 700 | 1 | _aAbernethy, D R | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 261 _gno. 3 _gp. 879-84 |
|
| 999 |
_c1608874 _d1608874 |
||